Back
Arcus Biosciences, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Sell
26
RCUS
Arcus Biosciences, Inc.
Last Price:
$23.11
Seasonality Move:
-9.85%
Buy
80
TVTX
Travere Therapeutics, Inc.
Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
26
Arcus Biosciences, Inc. (RCUS)
is a Sell
Is Arcus Biosciences, Inc. a Buy, Sell or Hold?
-
The current Arcus Biosciences, Inc. [RCUS] share price is $23.12. The Score for RCUS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
RCUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCUS Stock Price Chart
What is Arcus Biosciences, Inc.'s stock price today?
-
The Arcus Biosciences, Inc. share price today is $23.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $40.2800Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
RCUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.98 | Buy |
| Relative Strength Index (14 RSI): | 52.96 | Buy |
| Chaikin Money Flow: | 388340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.93 - 25.49) | Sell |
| Bollinger Bands (100): | (11.22 - 21.9) | Buy |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.67 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 1508490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.0318 - 36.4718) | Buy |
| Bollinger Bands (100): | (20.7309 - 34.2909) | Buy |
RCUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.43 | Buy |
| 20-day SMA: | 24.09 | Sell |
| 50-day SMA: | 21.33 | Buy |
| 200-day SMA: | 12.66 | Buy |
| 8-day EMA: | 17.68 | Buy |
| 20-day EMA: | 10.21 | Buy |
| 50-day EMA: | 4.82 | Buy |
| 200-day EMA: | 1.31 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.7 | Buy |
| 20-day SMA: | 35.23 | Buy |
| 50-day SMA: | 33.43 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 28.52 | Buy |
| 20-day EMA: | 16.32 | Buy |
| 50-day EMA: | 7.67 | Buy |
| 200-day EMA: | 2.09 | Buy |
Arcus Biosciences, Inc. Earnings Growth & RCUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.37 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Arcus Biosciences, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||